The L169P VHL variant was identified in the tumor of this aggressive case of ccRCC by whole-exome sequencing (WES), revealing a homozygous in-frame T506C transition that resulted in the L169P amino acid substitution [5]. The gene discussed is VHL; the disease is neoplasm.